Global Allergic Asthma Therapeutics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI02242304

Publication Date:

February 15, 2024

Pages:

123

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Allergic Asthma Therapeutics market size was valued at US$ 6511 million in 2023. With growing demand in downstream market, the Allergic Asthma Therapeutics is forecast to a readjusted size of US$ 7944.8 million by 2030 with a CAGR of 2.9% during review period.
The research report highlights the growth potential of the global Allergic Asthma Therapeutics market. Allergic Asthma Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Allergic Asthma Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Allergic Asthma Therapeutics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Allergic Asthma Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Allergic Asthma Therapeutics market. It may include historical data, market segmentation by Type (e.g., ASM-8, AXP-1275), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Allergic Asthma Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Allergic Asthma Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Allergic Asthma Therapeutics industry. This include advancements in Allergic Asthma Therapeutics technology, Allergic Asthma Therapeutics new entrants, Allergic Asthma Therapeutics new investment, and other innovations that are shaping the future of Allergic Asthma Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Allergic Asthma Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Allergic Asthma Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Allergic Asthma Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Allergic Asthma Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Allergic Asthma Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Allergic Asthma Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Allergic Asthma Therapeutics market.
Market Segmentation:
Allergic Asthma Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segmentation by application
Clinic
Research Center
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Allergic Asthma Therapeutics Market Size 2019-2030
2.1.2 Allergic Asthma Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Allergic Asthma Therapeutics Segment by Type
2.2.1 ASM-8
2.2.2 AXP-1275
2.2.3 Beta-escin
2.2.4 CHF-6001
2.2.5 CSL-311
2.2.6 Dalazatide
2.2.7 Others
2.3 Allergic Asthma Therapeutics Market Size by Type
2.3.1 Allergic Asthma Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Allergic Asthma Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Allergic Asthma Therapeutics Segment by Application
2.4.1 Clinic
2.4.2 Research Center
2.4.3 Hospital
2.4.4 Others
2.5 Allergic Asthma Therapeutics Market Size by Application
2.5.1 Allergic Asthma Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Allergic Asthma Therapeutics Market Size Market Share by Application (2019-2024)
3 Allergic Asthma Therapeutics Market Size by Player
3.1 Allergic Asthma Therapeutics Market Size Market Share by Players
3.1.1 Global Allergic Asthma Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Allergic Asthma Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Allergic Asthma Therapeutics by Regions
4.1 Allergic Asthma Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Allergic Asthma Therapeutics Market Size Growth (2019-2024)
4.3 APAC Allergic Asthma Therapeutics Market Size Growth (2019-2024)
4.4 Europe Allergic Asthma Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Allergic Asthma Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Allergic Asthma Therapeutics Market Size by Country (2019-2024)
5.2 Americas Allergic Asthma Therapeutics Market Size by Type (2019-2024)
5.3 Americas Allergic Asthma Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Allergic Asthma Therapeutics Market Size by Region (2019-2024)
6.2 APAC Allergic Asthma Therapeutics Market Size by Type (2019-2024)
6.3 APAC Allergic Asthma Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Allergic Asthma Therapeutics by Country (2019-2024)
7.2 Europe Allergic Asthma Therapeutics Market Size by Type (2019-2024)
7.3 Europe Allergic Asthma Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Allergic Asthma Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Allergic Asthma Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Allergic Asthma Therapeutics Market Forecast
10.1 Global Allergic Asthma Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Allergic Asthma Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Allergic Asthma Therapeutics Forecast
10.1.3 APAC Allergic Asthma Therapeutics Forecast
10.1.4 Europe Allergic Asthma Therapeutics Forecast
10.1.5 Middle East & Africa Allergic Asthma Therapeutics Forecast
10.2 Americas Allergic Asthma Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Allergic Asthma Therapeutics Market Forecast
10.2.2 Canada Allergic Asthma Therapeutics Market Forecast
10.2.3 Mexico Allergic Asthma Therapeutics Market Forecast
10.2.4 Brazil Allergic Asthma Therapeutics Market Forecast
10.3 APAC Allergic Asthma Therapeutics Forecast by Region (2025-2030)
10.3.1 China Allergic Asthma Therapeutics Market Forecast
10.3.2 Japan Allergic Asthma Therapeutics Market Forecast
10.3.3 Korea Allergic Asthma Therapeutics Market Forecast
10.3.4 Southeast Asia Allergic Asthma Therapeutics Market Forecast
10.3.5 India Allergic Asthma Therapeutics Market Forecast
10.3.6 Australia Allergic Asthma Therapeutics Market Forecast
10.4 Europe Allergic Asthma Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Allergic Asthma Therapeutics Market Forecast
10.4.2 France Allergic Asthma Therapeutics Market Forecast
10.4.3 UK Allergic Asthma Therapeutics Market Forecast
10.4.4 Italy Allergic Asthma Therapeutics Market Forecast
10.4.5 Russia Allergic Asthma Therapeutics Market Forecast
10.5 Middle East & Africa Allergic Asthma Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Allergic Asthma Therapeutics Market Forecast
10.5.2 South Africa Allergic Asthma Therapeutics Market Forecast
10.5.3 Israel Allergic Asthma Therapeutics Market Forecast
10.5.4 Turkey Allergic Asthma Therapeutics Market Forecast
10.5.5 GCC Countries Allergic Asthma Therapeutics Market Forecast
10.6 Global Allergic Asthma Therapeutics Forecast by Type (2025-2030)
10.7 Global Allergic Asthma Therapeutics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Aslan Pharmaceuticals Pte. Ltd.
11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Information
11.1.2 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Product Offered
11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aslan Pharmaceuticals Pte. Ltd. Main Business Overview
11.1.5 Aslan Pharmaceuticals Pte. Ltd. Latest Developments
11.2 Axikin Pharmaceuticals, Inc.
11.2.1 Axikin Pharmaceuticals, Inc. Company Information
11.2.2 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product Offered
11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Axikin Pharmaceuticals, Inc. Main Business Overview
11.2.5 Axikin Pharmaceuticals, Inc. Latest Developments
11.3 Baxalta Incorporated
11.3.1 Baxalta Incorporated Company Information
11.3.2 Baxalta Incorporated Allergic Asthma Therapeutics Product Offered
11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Baxalta Incorporated Main Business Overview
11.3.5 Baxalta Incorporated Latest Developments
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Information
11.4.2 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Product Offered
11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Chiesi Farmaceutici SpA Main Business Overview
11.4.5 Chiesi Farmaceutici SpA Latest Developments
11.5 Circassia Pharmaceuticals Plc
11.5.1 Circassia Pharmaceuticals Plc Company Information
11.5.2 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Product Offered
11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Circassia Pharmaceuticals Plc Main Business Overview
11.5.5 Circassia Pharmaceuticals Plc Latest Developments
11.6 CSL Limited
11.6.1 CSL Limited Company Information
11.6.2 CSL Limited Allergic Asthma Therapeutics Product Offered
11.6.3 CSL Limited Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CSL Limited Main Business Overview
11.6.5 CSL Limited Latest Developments
11.7 Fountain Biopharma Inc.
11.7.1 Fountain Biopharma Inc. Company Information
11.7.2 Fountain Biopharma Inc. Allergic Asthma Therapeutics Product Offered
11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fountain Biopharma Inc. Main Business Overview
11.7.5 Fountain Biopharma Inc. Latest Developments
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Information
11.8.2 GlaxoSmithKline Plc Allergic Asthma Therapeutics Product Offered
11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 GlaxoSmithKline Plc Main Business Overview
11.8.5 GlaxoSmithKline Plc Latest Developments
11.9 Hydra Biosciences, Inc.
11.9.1 Hydra Biosciences, Inc. Company Information
11.9.2 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Product Offered
11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hydra Biosciences, Inc. Main Business Overview
11.9.5 Hydra Biosciences, Inc. Latest Developments
11.10 Infinity Pharmaceuticals, Inc.
11.10.1 Infinity Pharmaceuticals, Inc. Company Information
11.10.2 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product Offered
11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Infinity Pharmaceuticals, Inc. Main Business Overview
11.10.5 Infinity Pharmaceuticals, Inc. Latest Developments
11.11 Kineta, Inc.
11.11.1 Kineta, Inc. Company Information
11.11.2 Kineta, Inc. Allergic Asthma Therapeutics Product Offered
11.11.3 Kineta, Inc. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Kineta, Inc. Main Business Overview
11.11.5 Kineta, Inc. Latest Developments
11.12 Mabtech Limited
11.12.1 Mabtech Limited Company Information
11.12.2 Mabtech Limited Allergic Asthma Therapeutics Product Offered
11.12.3 Mabtech Limited Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Mabtech Limited Main Business Overview
11.12.5 Mabtech Limited Latest Developments
11.13 Marinomed Biotechnologie GmbH
11.13.1 Marinomed Biotechnologie GmbH Company Information
11.13.2 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Product Offered
11.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Marinomed Biotechnologie GmbH Main Business Overview
11.13.5 Marinomed Biotechnologie GmbH Latest Developments
11.14 Mycenax Biotech Inc.
11.14.1 Mycenax Biotech Inc. Company Information
11.14.2 Mycenax Biotech Inc. Allergic Asthma Therapeutics Product Offered
11.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Mycenax Biotech Inc. Main Business Overview
11.14.5 Mycenax Biotech Inc. Latest Developments
11.15 NeoPharm Co., Ltd.
11.15.1 NeoPharm Co., Ltd. Company Information
11.15.2 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Product Offered
11.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 NeoPharm Co., Ltd. Main Business Overview
11.15.5 NeoPharm Co., Ltd. Latest Developments
11.16 Oxagen Limited
11.16.1 Oxagen Limited Company Information
11.16.2 Oxagen Limited Allergic Asthma Therapeutics Product Offered
11.16.3 Oxagen Limited Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Oxagen Limited Main Business Overview
11.16.5 Oxagen Limited Latest Developments
11.17 Panacea Biotec Limited
11.17.1 Panacea Biotec Limited Company Information
11.17.2 Panacea Biotec Limited Allergic Asthma Therapeutics Product Offered
11.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Panacea Biotec Limited Main Business Overview
11.17.5 Panacea Biotec Limited Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂